A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 170
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NMSCs
Long Form : nonmelanoma skin cancers
No. Year Title Co-occurring Abbreviation
2020 A comparative study of long interspersed element-1 protein immunoreactivity in cutaneous malignancies. BCC, HSCORE, LINE-1, L1, MM, SCC, TMA
2020 A Current Review on Drug Loaded Nanofibers: Interesting and Valuable Platform for Skin Cancer Treatment. BCCs, SCCs
2020 CO2 laser ablative fractional resurfacing photodynamic therapy for actinic keratosis and nonmelanoma skin cancer: a randomized split-side study. AFR, AKs, ALA, PDT
2020 De novo sequence assembly requires bioinformatic checking of chimeric sequences. HPV
2020 Delayed Reconstruction with Full-Thickness Skin Grafts Following Defect Size Reduction in Head and Neck Nonmelanoma Skin Cancer. ---
2020 Evaluation of the effect of surgical treatment on quality of life with the Dermatology Life Quality Index in patients with facial nonmelanoma skin cancer. BCC, DLQI, SCC
2020 Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for Immunotherapy. BCC, CSCC, MCC
2020 Insulin-like Growth Factor-1 Impacts p53 Target Gene Induction in UVB-irradiated Keratinocytes and Human Skin. IGF-1, pol eta, UVB
2020 Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study. CI, HRs
10  2020 Non-Melanoma Skin Cancers: Biological and Clinical Features. BCC, MCC, SCC
11  2020 Nonmelanoma Skin Cancers: Embryologically Relevant Sites and UV Exposure. BCCs, ERS
12  2020 Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review. PD-1, PD-L1
13  2020 Protective Effects of Dietary Grape on UVB-Mediated Cutaneous Damages and Skin Tumorigenesis in SKH-1 Mice. GP
14  2020 Recurrence rates following surgical excision of periocular basal cell carcinomas: systematic review and meta-analysis. BCCs, MMS
15  2020 Significance of SOX18 expression in nonmelanoma skin cancers for prediction of high-risk patients: a preliminary study. BCC, SCC, SK
16  2020 Silibinin and non-melanoma skin cancers. US, UVB
17  2020 The sirtuin 6: An overture in skin cancer. BCC, SCC
18  2020 The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer. QOL, SCI
19  2020 Use of the Skin Cancer Quality of Life Impact Tool (SCQOLIT) - a feasibility study in non-melanoma skin cancer. PROMs, QOL, SCQOLIT
20  2019 A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location. MMS
21  2019 An update on topical photodynamic therapy for clinical dermatologists. AK, PDT
22  2019 Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma). ---
23  2019 Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids. SRT
24  2019 DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice. UA, UV
25  2019 Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review. MMS
26  2019 Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant Recipients. KTRs
27  2019 Incidence of Malignancies in Patients Treated With Sirolimus Following HeartTransplantation. CI, CNI, HR, HT, IS, non-NMSC, PTLD, SRL
28  2019 Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI). BCC, DLQI, HRQoL
29  2019 Nicotinamide N-methyltransferase in nonmelanoma skin cancers. BCC, NNMT, SCC
30  2019 Optimal cosmetic outcomes for basal cell carcinoma: a retrospective study of nonablative laser management. BCCs, MMS, OCT, PDL, RCM
31  2019 Peri-operative delineation of non-melanoma skin cancer margins invivo with handheld reflectance confocal microscopy and video-mosaicking. MMS, RCM
32  2019 Quantity and characteristics of flap or graft repairs for skin cancer on the nose or ears: a comparison between Mohs micrographic surgery and plastic surgery. MMS
33  2019 Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies. AEs, MACEs, PYs, SAEs, SIs
34  2019 Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy. EAR, SIR
35  2019 Silibinin inhibits ultraviolet B radiation-induced mast cells recruitment and bone morphogenetic protein 2 expression in the skin at early stages in Ptch(+/-) mouse model of basal cell carcinoma. BCC, BMP-2, Ptch, UVB
36  2019 Skin cancer knowledge and photoprotective practices of organ transplant recipients. OTRs, UVR
37  2019 Skin Cancer: Squamous and Basal Cell Carcinomas. BCC, SCCs
38  2019 The Prognostic Value of Podoplanin Expression in Nonmelanoma Skin Cancers: Correlation With Lymphatic Vessel Density. BCC, BSC, SCC, SK
39  2019 Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer. BCC, cSCC, EMPD, MCC, PD-1
40  2019 UV exposure, preventive habits, risk perception, and occupation in NMSC patients: A case-control study in Trieste (NE Italy). ---
41  2019 UVB drives different stages of epigenome alterations during progression of skin cancer. IPA, UVB
42  2018 A Review of the Literature of Surgical and Nonsurgical Treatments of Invasive Squamous Cells Carcinoma. cSCC
43  2018 Collagen disruption as a marker for basal cell carcinoma in presurgical margin detection. OPI
44  2018 Cryosurgery + 5% 5-Fluorouracil for Treatment of Superficial Basal Cell Carcinoma and Bowen's Disease [Formula: see text]. sBCC, SCCIS
45  2018 Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute. BCC, MM, NB-UVB, SCC
46  2018 Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling. GLSE, Hh
47  2018 Immune consequences induced by photodynamic therapy in non-melanoma skin cancers: a review. PDT
48  2018 Mohs micrographic surgery for digital melanoma and nonmelanoma skin cancers. MMS
49  2018 Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan. CAS, EMPD, SCC
50  2018 Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers. AK, BCC, SCC
51  2018 Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature. IBD
52  2018 Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients. LTRs
53  2018 The economic burden of occupational non-melanoma skin cancer due to solar radiation. BCC, HRQoL, OOPCs, SCC, UV
54  2018 The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines. IBD, NZ
55  2018 Utilization of Topographical Mohs Micrographic Surgery Maps for Rapid Review of Clinicopathologic Characteristics of Nonmelanoma Skin Cancers of the Ear. BCCs, MMS, SCCs
56  2017 Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers. BCC, cSCC, MCC, MMs
57  2017 Daylight photodynamic therapy vs. Conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra-individual comparison study. AK, C-PDT, DL-PDT
58  2017 Does ultrasound measurement improve the accuracy of electronic brachytherapy in the treatment of superficial non-melanomatous skin cancer? EBT, US
59  2017 Long-Lived Epidermal Cancer-Initiating Cells. CICs
60  2017 Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response. beta-HPVs
61  2017 Malignancy and Janus Kinase Inhibition. RA
62  2017 Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. AKs, ATP
63  2017 Rapid visualization of nonmelanoma skin cancer. ---
64  2017 Skull Base Invasion Patterns and Survival Outcomes of Nonmelanoma Skin Cancers. BCC, CN, DSS, OS
65  2017 Surgical Treatment with Locoregional Flap for the Nose. ---
66  2017 The Effect of Conversion from a Calcineurin Inhibitor to Sirolimus on Skin Cancer Reduction in Post-renal Transplantation Patients. CNIs
67  2017 The feasibility of using ultrasound during follow-up for superficial non-melanoma skin cancers after electronic brachytherapy. EBT, US
68  2017 Unnecessary Cost of Post-Mohs Permanent Pathology. MMS
69  2017 Updates on the Management of Non-Melanoma Skin Cancer (NMSC). BCCs, NMSC, SCCs
70  2016 Concomitant cetuximab and radiation therapy: A possible promising strategy for locally advanced inoperable non-melanoma skin carcinomas. BCC, EGFR, SCC
71  2016 Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors. BCC, SCC
72  2016 Nonmelanoma Skin Cancer With Aggressive Subclinical Extension in Immunosuppressed Patients. HIV, IC, IS, NMSC-ASE, SOTRs
73  2016 Peritumoral inflammatory reaction in non-melanoma skin cancers - histological and immunohistochemical study. BCCs, SCCs
74  2016 Prevalence and Clinical Characteristics of Nonmelanoma Skin Cancers Among Hispanic and Asian Patients Compared With White Patients in the United States: A 5-Year, Single-Institution Retrospective Review. ---
75  2016 Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers. AK, BCC, IW, OW, SCC, SR, UV
76  2016 Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study. AR, CI, HR, MI, SM, VTE
77  2016 The Two Faces of Fractionated Photodynamic Therapy: Increasing Efficacy With Light Fractionation or Adjuvant Use of Fractional Laser Technology. ALA, MAL, PDT
78  2016 Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites. MMS
79  2015 Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report. BT
80  2015 Cutaneous malignancy of the head and neck. ---
81  2015 Dual S-100-AE1/3 Immunohistochemistry to Detect Perineural Invasion in Nonmelanoma Skin Cancers. IHC, PNI
82  2015 Giant neglected squamous cell carcinoma of the skin. cSCC, ECT
83  2015 Intraoperative imaging during Mohs surgery with reflectance confocal microscopy: initial clinical experience. RCM
84  2015 Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic center. AUC, MMS
85  2015 mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review. mTHPC, PDT
86  2015 Multiple skin cancers in a single patient: Multiple pigmented Bowen's disease, giant basal cell carcinoma, squamous cell carcinoma. BCC, BD
87  2015 Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study. AKs, IMIQ, MAL, PDT
88  2015 Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis. GPA, SIRs
89  2015 Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients. mTOR, SCCs, UV
90  2015 Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models. ALA, BCC, PDT, SCC
91  2014 Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis. CIs, IBD
92  2014 Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention. COX-2
93  2014 Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab. cSCCs
94  2014 Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes. beta HPVs, EV
95  2014 Histopathological evaluation of non-melanoma skin cancer. BCC, SCC
96  2014 Immunohistochemical Analysis of Cyclooxygenase-2 in Non-Melanocytic Skin Cancer: Correlation With Morphological Subtype and Histologic Grade. BCCs, COX-2, SCCs
97  2014 Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. BCC, SCC, UVR
98  2014 Location of nonmelanoma skin cancers in patients after kidney transplantation. ---
99  2014 Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma. ET, HU, MPNs, SCC
100  2013 Chemoprevention of nonmelanoma skin cancer. SCC